Clinical Trial Update: The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer [NA]

View source ↗

Summary

This clinical trial update reports on investigating SIX6 as a universal cancer biomarker for diagnosing non-muscle invasive bladder cancer, sponsored by Xijing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Xijing Hospital | Conditions: Non-muscle Invasive Bladder Cancer | NA | Status: ACTIVE_NOT_RECRUITING